Medline ® Abstract for Reference 50
of 'The ketogenic diet and other dietary therapies for the treatment of epilepsy'
50
TI
A blinded, crossover study of the efficacy of the ketogenic diet.
AU
Freeman JM, Vining EP, Kossoff EH, Pyzik PL, Ye X, Goodman SN
SO
Epilepsia. 2009;50(2):322. Epub 2008 Aug 19.
Despite over 80 years of use, the ketogenic diet (KD) has never been tested in a blinded manner. Twenty children with intractable Lennox-Gastaut syndrome (LGS) were fasted 36 h and then randomized to receive the classic KD in conjunction with a solution containing either 60 g/day of glucose or saccharin. Parents and physicians were blinded to both the solution composition and level of ketosis. A crossover to the KD with the alternate solution occurred following the sixth day and a repeat fast. A 24-h electroencephalography (EEG) was obtained at baseline and after each arm. After administration of the solution, there was moderate evidence of a reduction in parent-reported seizures between the glucose and saccharin arms, with a median difference of 1.5 seizures per day (p = 0.07). There was no reduction in the number of EEG-identified events, with a median reduction of 7 events per day (p = 0.33). Ketosis was not completely eliminated in the glucose-added arm.
AD
Departments of Neurology and Pediatrics, The John M Freeman Pediatric Epilepsy Center, Baltimore, Maryland, USA.
PMID
